A study by Hariharan et al. [55] revealed that the production of cytokine storm and severity of COVID‐19 can be reduced by immunomodulation during NF‐κB activation; additionally, degradation of IκB and TNF‐α inhibition may also play significant roles in the reduction of cytokine storm production. This evidence concerns the gene NFKB1 and COVID-19.